Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
Rubén Queiró, Juan D. Cañete, Carlos Montilla, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Sex- and gender-related differences in psoriatic arthritis
Sanjana Tarannum, Ying Ying Leung, Sindhu R. Johnson, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 9, pp. 513-526
Closed Access | Times Cited: 62
Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature
Laure Gossec, Dennis McGonagle, Т. В. Коротаева, et al.
The Journal of Rheumatology (2017) Vol. 45, Iss. 1, pp. 6-13
Open Access | Times Cited: 87
Assessing Disease Activity in Psoriatic Arthritis: A Literature Review
Laura Tucker, Laura C. Coates, Philip Helliwell
Rheumatology and Therapy (2018) Vol. 6, Iss. 1, pp. 23-32
Open Access | Times Cited: 52
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Ana‐Maria Orbai, Richard Holland, Ying Ying Leung, et al.
The Journal of Rheumatology (2018) Vol. 46, Iss. 8, pp. 990-995
Open Access | Times Cited: 51
Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis
Benjamin Hagège, Elina Tan, M. Gayraud, et al.
Lara D. Veeken (2020) Vol. 59, Iss. 8, pp. 1818-1825
Open Access | Times Cited: 42
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
Lihi Eder, Dafna D. Gladman, Philip J. Mease, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002718-e002718
Open Access | Times Cited: 14
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III Study
Laura C. Coates, Philip J. Mease, Laure Gossec, et al.
Arthritis Care & Research (2018) Vol. 70, Iss. 10, pp. 1529-1535
Open Access | Times Cited: 41
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
Laura C. Coates, Ana‐Maria Orbai, Valdeŕilio Feijó Azevedo, et al.
Health and Quality of Life Outcomes (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 36
Causal association of leisure sedentary behavior with arthritis: A Mendelian randomization analysis
Ziqin Cao, Qiangxiang Li, Yajia Li, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 59, pp. 152171-152171
Open Access | Times Cited: 11
Treat-to-target in PsA: methods and necessity
Emma Dures, Sasha Shepperd, Sandeep Mukherjee, et al.
RMD Open (2020) Vol. 6, Iss. 1, pp. e001083-e001083
Open Access | Times Cited: 30
Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis
Kim Wervers, Marijn Vis, Ilja Tchetveriko, et al.
Arthritis Care & Research (2018) Vol. 70, Iss. 12, pp. 1764-1770
Open Access | Times Cited: 32
Measurement properties of the minimal disease activity criteria for psoriatic arthritis
Laura C. Coates, Vibeke Strand, Hilary Wilson, et al.
RMD Open (2019) Vol. 5, Iss. 2, pp. e001002-e001002
Open Access | Times Cited: 29
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity
Laura C. Coates, Ana‐Maria Orbai, Akimichi Morita, et al.
BMC Rheumatology (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 28
Comparison of disease activity measures in early psoriatic arthritis in usual care
Kim Wervers, Jolanda J. Luime, Ilja Tchetverikov, et al.
Lara D. Veeken (2019) Vol. 58, Iss. 12, pp. 2251-2259
Open Access | Times Cited: 26
Prevalence and risk factors associated with psoriatic arthritis among patients with psoriasis
Yin Pin Loo, Chai Har Loo, Ai Lee Lim, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 9, pp. 1788-1798
Closed Access | Times Cited: 9
Sex-specific differences in patients with psoriatic arthritis:a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV)
Shihao He, Fan Yang, Chaofan Lu, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1063-1071
Closed Access | Times Cited: 3
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
Laure Gossec, Ana‐Maria Orbai, Laura C. Coates, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003548-e003548
Open Access | Times Cited: 3
Role of Methotrexate in the Management of Psoriatic Arthritis
Musaab Elmamoun, Vinod Chandran
Drugs (2018) Vol. 78, Iss. 6, pp. 611-619
Closed Access | Times Cited: 27
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Laura Tucker, Weiyu Ye, Laura C. Coates
Current Rheumatology Reports (2018) Vol. 20, Iss. 11
Open Access | Times Cited: 26
Measuring Outcomes in Psoriatic Arthritis
Alexis Ogdie, Laura C. Coates, Philip J. Mease
Arthritis Care & Research (2020) Vol. 72, Iss. S10, pp. 82-109
Open Access | Times Cited: 21
Effect of Fatigue on Health-Related Quality of Life and Work Productivity in Psoriatic Arthritis: Findings From a Real-World Survey
Laure Gossec, Jessica A. Walsh, Kaleb Michaud, et al.
The Journal of Rheumatology (2022), pp. jrheum.211288-jrheum.211288
Open Access | Times Cited: 14
Outcome measures in psoriatic arthritis: Where next?
Simon Hackett, Laura C. Coates
Musculoskeletal Care (2022) Vol. 20, Iss. S1
Open Access | Times Cited: 13
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
Rubén Queiró, Juan D. Cañete, Carlos Montilla, et al.
The Journal of Rheumatology (2019) Vol. 46, Iss. 7, pp. 710-715
Open Access | Times Cited: 19
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 12, pp. 1303-1312
Closed Access | Times Cited: 18
Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis
Kim Wervers, Jolanda J. Luime, Ilja Tchetverikov, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top